Advancing cancer innovation through scalable, gentle and meaningful cell culture
The PSCC Innovation Forum 2026, organized by the Paris Saclay Cancer Cluster, has become a cornerstone event for the European life sciences ecosystem. It sits at the crossroads of academic research, clinical innovation and industrial deployment. The forum brings together a diverse community of stakeholders committed to accelerating progress in oncology.
What makes this event distinctive is not only the scientific quality of the discussions, but also the shared ambition to move beyond proof-of-concept. The PSCC Innovation Forum addresses a fundamental question faced by the field: how can cutting-edge biological insights translate into robust, scalable and impactful solutions for patients?
As cancer research increasingly relies on complex biological systems, this challenge has never been more pressing.
From advanced biology to operational reality
Over the past decade, oncology research has undergone a profound transformation. Traditional 2D models are giving way to advanced 3D systems, including organoids, stem-cell–derived models and immune cell platforms. These approaches offer higher physiological relevance and improved predictive value. At the same time, they introduce new layers of complexity.
In practice, this complexity leads to several recurring challenges:
High sensitivity of cells to mechanical and environmental stress
Difficulties in maintaining homogeneity and reproducibility over time
Limited transferability from small-scale experiments to larger production volumes
The scientific community widely acknowledges these limitations. However, many technologies still struggle to address them effectively. Solutions often perform well in controlled laboratory settings, but encounter difficulties during scale-up, standardization and long-term use.
The PSCC Innovation Forum tackles these issues head-on. It highlights technologies and approaches designed to bridge the gap between biological sophistication and operational feasibility.
Why gentle scalability matters in cancer research
As cellular models become more fragile and functionally specialized, mechanical forces emerge as a decisive variable. Shear stress, heterogeneous mixing and poorly controlled culture conditions can alter cell behavior. In many cases, these effects remain invisible until late-stage validation.
This challenge is particularly critical in oncology:
subtle shifts in cell phenotype can affect drug response,
loss of stemness or functionality can limit translational relevance,
variability reduces reproducibility and comparability across studies.
A clear consensus is emerging across the field. Scalability without gentleness is no longer acceptable, just as gentleness without scalability is no longer sufficient. Addressing both dimensions together now shapes the future of cancer innovation.
Cellura’s presence at PSCC Innovation Forum 2026
It is within this context that Cellura will participate in the PSCC Innovation Forum 2026. Our involvement reflects a deliberate choice to engage in discussions that go beyond product positioning. Instead, we focus on the methodological and technological foundations of modern cell culture.
Cellura’s work follows a simple principle: cells should never adapt to technology; technology should adapt to cells. This philosophy becomes increasingly relevant as research turns toward fragile and highly sensitive cellular systems. These models require precise control of their physical environment.
At the forum, Cellura approaches these topics as an opportunity to:
exchange with researchers facing real-world culture limitations,
discuss scale-up strategies that preserve biological integrity,
explore how gentle 3D culture can support more reliable translational outcomes.
This approach aligns naturally with the spirit of the PSCC Innovation Forum. The event values substance, dialogue and long-term impact over short-term visibility.
An ecosystem built on dialogue and convergence
One of the forum’s strengths lies in its ability to foster cross-disciplinary dialogue. Scientists, clinicians, engineers and industrial players do more than coexist. They actively challenge assumptions and constraints.
For technology developers, this environment is invaluable. It helps clarify how innovations are used in practice and where gaps remain between design intentions and experimental realities.
From Cellura’s perspective, such exchanges ensure that future developments stay aligned with:
the biological demands of advanced cancer models,
the operational constraints of research and production environments,
and the ethical and regulatory expectations shaping tomorrow’s standards.
Shaping the future of bioproduction together
The PSCC Innovation Forum 2026 is more than an event. It reflects a broader transition across the life sciences. Cancer research increasingly relies on models that are more human-relevant, more predictive and more scalable. At the same time, industry seeks platforms that support this evolution without compromising scientific rigor.
Cellura’s participation forms part of this collective trajectory. By contributing to discussions on gentle, scalable and reproducible 3D cell culture, we aim to support an ecosystem built on solid foundations rather than technical compromises.
As oncology continues to evolve, progress will depend not only on biological discovery. It will also depend on the technologies that make these discoveries usable, reliable and scalable. The PSCC Innovation Forum provides a unique space to address these challenges openly, and Cellura is proud to be part of this ongoing conversation.
About the event
You may find more information about the PSCC Innovation Forum 2026 on the official event page: https://www.parissaclaycancercluster.org/event-details/pscc-innovation-forum-2026
For further information or to arrange a meeting:
Email: contact@cellura.io
